From Chair to Chart: The VELscope Mantis Now Integrates with SOTA Cloud
June 22, 2026 No Comments
Read More » 
VELscope Mantis is a state-of-the-art oral mucosal examination tool to assist the dental professional in performing comprehensive oral examinations. The Mantis integrates both traditional white light visualization, polarized white light visualization and blue-light-induced fluorescence visualization into the same device.
The VELscope system enhances oral mucosal examinations by using fluorescence to help visualize oral mucosal tissues. It’s quick, dye-free, and easily performed during routine dental visits in about two minutes. As an adjunctive tool, it supports, not replaces, the traditional head and neck exam.
VELscope uses a safe blue light to make oral mucosal tissue naturally fluoresce, helping dentists visualize oral mucosal tissues during routine examinations.
VELscope is used alongside the comprehensive oral exam to help visualize and photo-document oral mucosal tissues, supporting a thorough routine examination.
When found early, oral cancer has an 83% five-year survival rate—but that drops to 40% when found late. VELscope helps detect issues sooner, improving outcomes through earlier diagnosis.
Oral cancer risk factors now include HPV16, along with tobacco, alcohol use, weak immunity, and cancer history—making regular screenings more important than ever.
Did you know patients are actively searching for VELscope providers? By completing this training, you’ll be listed as a certified VELscope provider on our map, where patients can easily find you!
It’s simple:
VELscope not only enhances visualization of cancer related lesions but also many other types of more common abnormalities which when found promptly and dealt with appropriately can improve patient health and benefit quality of life.
OralMedicine.com empowers dentists and dental hygienists to enhance patient care by enabling direct case uploads to expert oral pathologists. This streamlined process supports early detection of oral cancer and other abnormalities, ensuring more informed clinical decisions.
